Psychiatric Disorders in Addiction - Interest of Screening and Influence on Relapse
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Psychiatric Disorders. Basic parameters: from 16 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
In complex detoxification hospital units, patients receive a common care system (interviews, therapeutic workshops, support for discharges, etc.). In the event of a relapse during hospitalization, i.e., a relapse into addiction, hospital care is called into question, and discharge is generally considered. A key care issue is therefore to prevent these relapses by identifying risk profiles to strengthen their management. According to studies, psychiatric diagnoses increase the risk of relapse, but the investigators do not fully understand which ones or to what extent. The objective of this study is to analyze the influence of psychiatric diagnoses on the risk of relapse. This would allow for adapting the care of these patients to reduce this risk. The investigators are also seeking to study the value of screening questionnaires in improving the reliability of psychiatric diagnoses.
Primary outcome measures
- Insomnia Severity Score (ISI) [Time frame: At 22 months]
- Depression Scale Score (PHQ 9) [Time frame: At 22 months]
- Anxiety score (GAD-7) [Time frame: At 22 months]
- Posttraumatic Stress Disorder Score (PCL-5) [Time frame: At 22 months]
- Addictions Score (DAST-10) [Time frame: At 22 months]
- ADHD Score [Time frame: At 22 months]
- Autism Score (RAADS-14) [Time frame: At 22 months]
- Emotion Dysregulation Score (DERS-16) [Time frame: At 22 months]
Eligibility criteria
Inclusion criteria
- Subject aged ≥16
- Having been hospitalized in the complex withdrawal unit of the Strasbourg psychiatric clinic during the period from January 1, 2024 to November 1, 2024
Exclusion criteria
- Refusal to participate in the study
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Case-only
Study locations
France · 1 center
- Service d'Addictologie - CHU de Strasbourg - France — Strasbourg
Identifiers
NCT: NCT07023419 · 9533